Ghislaine Prévot

Presence of<i>Leishmania</i>RNA Virus 1 in<i>Leishmania guyanensis</i>Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse

Eliane Bourreau, Marine Ginouvès, Ghislaine Prévot et al. · The Journal of Infectious Diseases · 2015 · 130 citations · Full text

Experimental Murine Leishmaniasis, Diagnostic Virology, Leishmania Guyanensis Infections +14

Differential Production of Systemic and Intralesional Gamma Interferon and Interleukin-10 in Nodular and Ulcerative Forms of Buruli Disease

Ghislaine Prévot, Eliane Bourreau, Hervé Pascalis et al. · Infection and Immunity · 2004 · 76 citations · Full text

High Intralesional Interleukin‐10 Messenger RNA Expression in Localized Cutaneous Leishmaniasis Is Associated with Unresponsiveness to Treatment

Eliane Bourreau, Ghislaine Prévot, Jacques Gardon et al. · The Journal of Infectious Diseases · 2001 · 64 citations · Full text

Immunodeficiencies, Immunology, Dermatology +16

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2017 update. Full-length version

Vincent Cottin, B. Crestani, J. Cadranel et al. · Revue des Maladies Respiratoires · 2017 · 63 citations · Full text

Fibrosis, Pulmonary Care, Advanced Lung Disease +7

Interleukin (IL)–13 Is the Predominant Th2 Cytokine in Localized Cutaneous Leishmaniasis Lesions and Renders Specific CD4⁺T Cells Unresponsive to IL‐12

Eliane Bourreau, Ghislaine Prévot, R. Pradinaud et al. · The Journal of Infectious Diseases · 2001 · 54 citations